NDA

Beyond's analysis on NDA

• 2026-08-10 — Ocumension files NDA in China for Nicox’s NCX 470 glaucoma therapy, marking a key regulatory milestone for the ophthalmic asset
• 2026-08-10 — Nicox and partner Ocumension submit NDA for NCX 470 in China, targeting approval for a novel nitric oxide-donating glaucoma therapy

Recent news mentioning NDA

• 2026-09-07 — La eurozona creció más de lo esperado entre abril y junio, un 0,6%, gracias a Alemania e Irlanda
• 2026-09-07 — HelloNation Explains Fire Extinguisher Inspection Indiana Standards With Insights From Fire Protection Expert Jeff Long
• 2026-09-07 — Hyundai India to invest Rs450bn, launch 26 models by 2030 – report
• 2026-09-07 — Bitcoin and ethereum prices today, Monday, September 7, 2026: Crypto investors on rate watch
• 2026-09-07 — SPH CONSULTING GROUP'S STRATEGIC ADVISORY WORK HELPED LAY THE FOUNDATION FOR HISTORIC KEAN-NJCU MERGER
• 2026-09-07 — La compraventa de vivienda cae un 7,7% en julio, el mayor descenso en más de dos años
• 2026-09-07 — Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims
• 2026-09-07 — La leyenda del FC Barcelona, Carles Puyol, se une a Midea en IFA 2026.
• 2026-09-07 — El Gobierno lanza ‘El portal de Casa 47′, su buscador de vivienda pública
• 2026-09-07 — Best high-yield savings interest rates today, Monday, September 7, 2026: Earn up to 4.10% APY
• 2026-09-07 — Best CD rates today, Monday, September 7, 2026: Lock in up to 4.35% APY
• 2026-09-07 — Mortgage and refinance interest rates today, Monday, September 7, 2026: Fixed purchase rates lower than refi rates

Appears alongside

• China
• NMPA
• NCX
• Chine
• Ocumension
• AP301
• PolyPid
• FDA

Browse the full archive →